000590 古汉医药
已收盘 10-30 15:00:00
资讯
新帖
简况
古汉医药(000590)9月30日股东户数1.57万户，较上期增加14.04%
证券之星 · 19:16
古汉医药(000590)9月30日股东户数1.57万户，较上期增加14.04%
图解古汉医药三季报：第三季度单季净利润同比下降476.53%
证券之星 · 02:44
图解古汉医药三季报：第三季度单季净利润同比下降476.53%
古汉医药：公司严格按照《公司法》《证券法》及证监会、深交所有关规定开展定期报告编制工作
证券之星 · 10-21
古汉医药：公司严格按照《公司法》《证券法》及证监会、深交所有关规定开展定期报告编制工作
古汉医药（000590）披露独立董事取得独立董事培训证明的公告，9月14日股价上涨0.88%
证券之星 · 09-14
古汉医药（000590）披露独立董事取得独立董事培训证明的公告，9月14日股价上涨0.88%
股市必读：古汉医药新发布《关于控股子公司重大诉讼事项的进展公告》
证券之星 · 09-14
股市必读：古汉医药新发布《关于控股子公司重大诉讼事项的进展公告》
古汉医药（000590）披露控股子公司重大诉讼事项进展公告，9月11日股价下跌2.27%
证券之星 · 09-11
古汉医药（000590）披露控股子公司重大诉讼事项进展公告，9月11日股价下跌2.27%
古汉医药（000590）披露控股股东之一致行动人增持计划实施完成公告，9月10日股价下跌2.01%
证券之星 · 09-10
古汉医药（000590）披露控股股东之一致行动人增持计划实施完成公告，9月10日股价下跌2.01%
9月9日古汉医药发布公告，股东增持150.87万股
证券之星 · 09-09
9月9日古汉医药发布公告，股东增持150.87万股
古汉医药（000590）2026年中报简析：亏损收窄
证券之星 · 08-28
古汉医药（000590）2026年中报简析：亏损收窄
股市必读：古汉医药中报 - 第二季度单季净利润同比下降792.40%
证券之星 · 08-28
股市必读：古汉医药中报 - 第二季度单季净利润同比下降792.40%
图解古汉医药中报：第二季度单季净利润同比下降792.40%
证券之星 · 08-27
图解古汉医药中报：第二季度单季净利润同比下降792.40%
股市必读：7月17日古汉医药发布公告，股东增持239.47万股
证券之星 · 07-20
股市必读：7月17日古汉医药发布公告，股东增持239.47万股
7月17日古汉医药发布公告，股东增持239.47万股
证券之星 · 07-17
7月17日古汉医药发布公告，股东增持239.47万股
古汉医药(000590.SZ)：上海赛乐仙累计增持1%股份
中金财经 · 07-17
古汉医药(000590.SZ)：上海赛乐仙累计增持1%股份
古汉医药（000590）披露2026年半年度业绩预告，7月15日股价上涨1.08%
证券之星 · 07-15
古汉医药（000590）披露2026年半年度业绩预告，7月15日股价上涨1.08%
古汉医药：预计2026年1-6月归属净利润亏损1300万元至1800万元
证券之星 · 07-14
古汉医药：预计2026年1-6月归属净利润亏损1300万元至1800万元
古汉医药（000590）披露董事会换届及高管聘任公告，6月22日股价上涨0.88%
证券之星 · 06-22
古汉医药（000590）披露董事会换届及高管聘任公告，6月22日股价上涨0.88%
每周股票复盘：古汉医药（000590）2025年度股东会顺利召开
证券之星 · 06-21
每周股票复盘：古汉医药（000590）2025年度股东会顺利召开
古汉医药（000590）披露2025年度股东会决议公告，6月17日股价下跌1.08%
证券之星 · 06-17
古汉医药（000590）披露2025年度股东会决议公告，6月17日股价下跌1.08%
6月9日古汉医药发布公告，股东增持239.47万股
证券之星 · 06-09
6月9日古汉医药发布公告，股东增持239.47万股
加载更多
公司概况
公司名称：
古汉医药集团股份公司
所属行业：
医药制造业
上市日期：
1996-01-19
主营业务：
古汉医药集团股份公司的主营业务是医药大健康领域的拓展深耕，产品涵盖中药、化药、保健食品三大板块。公司的主要产品是古汉养生精。公司获得了“古汉”商标为中国驰名商标、中华老字号，古汉养生精制作技艺列入湖南省非物质文化遗产。
发行价格：
6.00
{"stockData":{"symbol":"000590","market":"SZ","secType":"STK","nameCN":"古汉医药","latestPrice":7.74,"timestamp":1793343810000,"preClose":8.03,"halted":0,"volume":3997305,"delay":0,"changeRate":-0.0361,"floatShares":239000000,"shares":239000000,"eps":-0.2486,"marketStatus":"已收盘","change":-0.29,"latestTime":"10-30 15:00:00","open":7.8,"high":8.1,"low":7.7,"amount":31363700,"amplitude":0.0498,"askPrice":7.75,"askSize":65,"bidPrice":7.74,"bidSize":33,"shortable":0,"etf":0,"ttmEps":-0.2486,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":8.03,"symbolType":"stock","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":8.83,"lowLimit":7.23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":239471267,"isCdr":false,"pbRate":3.61,"roa":"--","roe":"--","epsLYR":-0.211,"committee":0.481728,"marketValue":1854000000,"turnoverRate":0.0167,"status":1,"floatMarketCap":1853000000},"requestUrl":"/m/hq/s/000590","defaultTab":"news","newsList":[{"id":"2679213621","title":"古汉医药(000590)9月30日股东户数1.57万户，较上期增加14.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679213621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679213621?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:16","pubTimestamp":1793358987,"startTime":"0","endTime":"0","summary":"证券之星消息，近日古汉医药披露，截至2026年9月30日公司股东户数为1.57万户，较6月30日增加1933.0户，增幅为14.04%。在中药行业个股中，古汉医药股东户数低于行业平均水平，截至9月30日，中药行业平均股东户数为5.33万户。从股价来看，2026年6月30日至2026年9月30日，古汉医药区间涨幅为11.38%，在此期间股东户数增加1933.0户，增幅为14.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000047085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679238913","title":"图解古汉医药三季报：第三季度单季净利润同比下降476.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679238913","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679238913?lang=zh_cn&edition=full","pubTime":"2026-10-30 02:44","pubTimestamp":1793299443,"startTime":"0","endTime":"0","summary":"证券之星消息，古汉医药2026年三季报显示，前三季度公司主营收入2.2亿元，同比下降2.1%；归母净利润-2381.55万元，同比下降60.69%；扣非净利润-2843.65万元，同比下降37.49%；其中2026年第三季度，公司单季度主营收入8592.88万元，同比上升4.31%；单季度归母净利润-884.63万元，同比下降476.53%；单季度扣非净利润-1128.6万元，同比下降672.79%；负债率40.07%，投资收益86.11万元，财务费用108.3万元，毛利率42.16%。财报数据概要请见下图:本文数据来源于古汉医药2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000005496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677267146","title":"古汉医药：公司严格按照《公司法》《证券法》及证监会、深交所有关规定开展定期报告编制工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2677267146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677267146?lang=zh_cn&edition=full","pubTime":"2026-10-21 20:48","pubTimestamp":1792586889,"startTime":"0","endTime":"0","summary":"证券之星消息，古汉医药10月20日在投资者关系平台上答复投资者关心的问题。公司严格按照《公司法》《证券法》及证监会、深交所有关规定开展定期报告编制工作，报告由公司相关职能部门结合公司实际经营及发展情况撰写，并履行内部复核审批程序，确保定期报告内容真实、准确、完整。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100039060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000590","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667652538","title":"古汉医药（000590）披露独立董事取得独立董事培训证明的公告，9月14日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667652538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667652538?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:39","pubTimestamp":1789378788,"startTime":"0","endTime":"0","summary":"截至2026年9月14日收盘，古汉医药报收于9.14元，较前一交易日上涨0.88%，最新总市值为21.89亿元。该股当日开盘9.13元，最高9.25元，最低8.99元，成交额达2531.5万元，换手率为1.16%。公告显示，公司于2026年5月25日提名郭东芳女士为第十一届董事会独立董事候选人，并经2026年6月17日召开的2025年度股东会审议通过，选举其为独立董事。截至股东会通知发出日，郭东芳女士尚未取得深圳证券交易所认可的独立董事培训证明，已书面承诺将按规定参训。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400023666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638772","title":"股市必读：古汉医药新发布《关于控股子公司重大诉讼事项的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638772?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:17","pubTimestamp":1789330630,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，古汉医药报收于9.06元，下跌2.27%，换手率1.19%，成交量2.85万手，成交额2581.57万元。公司公告汇总：控股子公司重大诉讼一审胜诉，法院判令被告一退还合同款2000万元并支付赔偿金，被告二、被告三承担连带清偿责任；该判决尚未生效，公司已对相关应收款项全额计提坏账准备。该判决尚未生效，对方有权提起上诉，最终执行结果存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666957897","title":"古汉医药（000590）披露控股子公司重大诉讼事项进展公告，9月11日股价下跌2.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666957897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666957897?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:37","pubTimestamp":1789137434,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，古汉医药报收于9.06元，较前一交易日下跌2.27%，最新总市值为21.7亿元。该股当日开盘9.25元，最高9.27元，最低8.99元，成交额达2581.57万元，换手率为1.19%。近日，古汉医药集团股份公司披露其控股子公司湖南启迪药业生物有限公司与宁波医多多电子商务有限公司、福州市乐拓企业管理有限公司、北京涂多多电子商务股份有限公司之间的买卖合同纠纷案已获一审判决。该判决尚未生效，对方有权提起上诉，最终执行结果存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666507562","title":"古汉医药（000590）披露控股股东之一致行动人增持计划实施完成公告，9月10日股价下跌2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666507562","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666507562?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:09","pubTimestamp":1789034982,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，古汉医药报收于9.27元，较前一交易日下跌2.01%，最新总市值为22.2亿元。古汉医药近日披露《关于控股股东之一致行动人增持公司股份计划实施完成的公告》。本次增持后，控股股东及其一致行动人合计持有公司66,165,882股，占总股本27.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000034263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377584","title":"9月9日古汉医药发布公告，股东增持150.87万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377584","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666377584?lang=zh_cn&edition=full","pubTime":"2026-09-09 18:01","pubTimestamp":1788948069,"startTime":"0","endTime":"0","summary":"证券之星消息，9月9日古汉医药发布公告《古汉医药:关于控股股东之一致行动人增持公司股份计划实施完成的公告》，其股东上海赛乐仙企业管理咨询有限公司于2026年7月18日至2026年9月9日间合计增持150.87万股，占公司目前总股本的0.63%，变动期间该股股价上涨15.23%，截止9月9日收盘报9.46元。股东增减持详情见下表：根据古汉医药2026年中报公布的十大股东详情如下：本文数据来源于古汉医药公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900030866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039334","title":"古汉医药（000590）2026年中报简析：亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039334","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039334?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:23","pubTimestamp":1787869405,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期古汉医药发布2026年中报。根据财报显示，古汉医药亏损收窄。截至本报告期末，公司营业总收入1.34亿元，同比下降5.8%，归母净利润-1496.92万元，同比上升12.82%。本次财报公布的各项数据指标表现一般。财报体检工具显示：建议关注公司现金流状况本文数据来源于古汉医药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603630","title":"股市必读：古汉医药中报 - 第二季度单季净利润同比下降792.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603630","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662603630?lang=zh_cn&edition=full","pubTime":"2026-08-28 05:44","pubTimestamp":1787867055,"startTime":"0","endTime":"0","summary":"当日关注点交易信息汇总：8月27日主力资金净流入308.04万元，占总成交额5.96%； 股本股东变化：截至2026年6月30日股东户数为1.38万户，较3月31日减少6.88%； 业绩披露要点：2026年中报归母净利润为-1496.92万元，同比上升12.82%，但第二季度单季归母净利润同比下降792.4%； 公司公告汇总：公司将于2026年9月2日参加湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662749400","title":"图解古汉医药中报：第二季度单季净利润同比下降792.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749400","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662749400?lang=zh_cn&edition=full","pubTime":"2026-08-27 02:58","pubTimestamp":1787770722,"startTime":"0","endTime":"0","summary":"证券之星消息，古汉医药2026年中报显示，上半年度公司主营收入1.34亿元，同比下降5.8%；归母净利润-1496.92万元，同比上升12.82%；扣非净利润-1715.04万元，同比上升24.29%；其中2026年第二季度，公司单季度主营收入6250.69万元，同比下降19.05%；单季度归母净利润-815.56万元，同比下降792.4%；单季度扣非净利润-962.31万元，同比下降73.01%；负债率38.37%，投资收益76.0万元，财务费用72.75万元，毛利率43.4%。财报数据概要请见下图:本文数据来源于古汉医药2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700007144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652257277","title":"股市必读：7月17日古汉医药发布公告，股东增持239.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652257277","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652257277?lang=zh_cn&edition=full","pubTime":"2026-07-20 03:02","pubTimestamp":1784487736,"startTime":"0","endTime":"0","summary":"股本股东变化：上海赛乐仙于6月10日至7月17日增持239.47万股，占总股本1.0%，权益变动触及1%整数倍。股本股东变化股东增减持7月17日古汉医药发布公告《古汉医药:关于控股股东之一致行动人增持公司股份的进展情况暨权益变动触及1%整数倍的提示性公告》，其股东上海赛乐仙企业管理咨询有限公司于2026年6月10日至2026年7月17日间合计增持239.47万股，占公司目前总股本的1.0%，变动期间该股股价下跌12.47%，截止7月17日收盘报8.21元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000001430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652288982","title":"7月17日古汉医药发布公告，股东增持239.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652288982","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652288982?lang=zh_cn&edition=full","pubTime":"2026-07-17 20:01","pubTimestamp":1784289675,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日古汉医药发布公告《古汉医药:关于控股股东之一致行动人增持公司股份的进展情况暨权益变动触及1%整数倍的提示性公告》，其股东上海赛乐仙企业管理咨询有限公司于2026年6月10日至2026年7月17日间合计增持239.47万股，占公司目前总股本的1.0%，变动期间该股股价下跌12.47%，截止7月17日收盘报8.21元。股东增减持详情见下表：根据古汉医药2026年一季报公布的十大股东详情如下：本文数据来源于古汉医药公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700040027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652407576","title":"古汉医药(000590.SZ)：上海赛乐仙累计增持1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2652407576","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652407576?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:47","pubTimestamp":1784285223,"startTime":"0","endTime":"0","summary":"格隆汇7月17日丨古汉医药(000590.SZ)公布，截至本公告披露日，上海赛乐仙于2026年6月10日至2026年7月17日期间，通过集中竞价交易的方式增持公司239.47万股股份，占公司总股本的1.00%，增持金额合计人民币20,855,937.10元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260717/32310895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0122","BK0239","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451108","title":"古汉医药（000590）披露2026年半年度业绩预告，7月15日股价上涨1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651451108?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:58","pubTimestamp":1784109525,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，古汉医药报收于8.4元，较前一交易日上涨1.08%，最新总市值为20.12亿元。该股当日开盘8.26元，最高8.49元，最低8.2元，成交额达3709.23万元，换手率为1.85%。古汉医药集团股份公司于2026年7月15日披露《2026年半年度业绩预告》，预计2026年1月1日至6月30日归属于上市公司股东的净利润为-1,800.00万元至-1,300.00万元，上年同期为-1,717.01万元；扣除非经常性损益后的净利润为-2,100.00万元至-1,500.00万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500035718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000590","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651030761","title":"古汉医药：预计2026年1-6月归属净利润亏损1300万元至1800万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651030761","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651030761?lang=zh_cn&edition=full","pubTime":"2026-07-14 20:13","pubTimestamp":1784031192,"startTime":"0","endTime":"0","summary":"证券之星消息，古汉医药发布业绩预告，预计2026年1-6月归属净利润亏损1300万元至1800万元。（二）上年同期，公司收到古汉广东原股东因未完成业绩承诺支付的业绩补偿款，对应转回信用减值损失约 600 万元，增加上年同期净利润；本期无该类收益。古汉医药2026年一季报显示，一季度公司主营收入7166.79万元，同比上升9.89%；归母净利润-681.35万元，同比上升58.09%；扣非净利润-752.73万元，同比上升55.95%；负债率38.05%，财务费用41.05万元，毛利率42.81%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400044523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645902307","title":"古汉医药（000590）披露董事会换届及高管聘任公告，6月22日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645902307","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645902307?lang=zh_cn&edition=full","pubTime":"2026-06-22 17:50","pubTimestamp":1782121836,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，古汉医药报收于9.21元，较前一交易日上涨0.88%，最新总市值为22.06亿元。近日，古汉医药集团股份公司发布《关于完成董事会换届选举及聘任高级管理人员、证券事务代表的公告》。公告显示，公司于2026年6月完成董事会换届选举，选举江琎为董事长、倪小桥为副董事长，组成第十一届董事会，包括4名非独立董事和3名独立董事。原独立董事黄文表任期届满离任。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200027147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645096092","title":"每周股票复盘：古汉医药（000590）2025年度股东会顺利召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2645096092","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645096092?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:43","pubTimestamp":1781984589,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，古汉医药报收于9.13元，较上周的9.3元下跌1.83%。本周，古汉医药6月15日盘中最高价报9.5元。本周关注点公司公告汇总：古汉医药2025年度股东会于2026年6月17日召开，会议表决程序合法，决议有效。公司公告汇总湖南启元律师事务所对古汉医药集团股份公司2025年度股东会进行现场见证，并出具法律意见书。出席会议股东共97人，代表股份占公司总股本的49.1778%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644043742","title":"古汉医药（000590）披露2025年度股东会决议公告，6月17日股价下跌1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644043742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644043742?lang=zh_cn&edition=full","pubTime":"2026-06-17 23:00","pubTimestamp":1781708451,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，古汉医药报收于9.17元，较前一交易日下跌1.08%，最新总市值为21.96亿元。该股当日开盘9.37元，最高9.38元，最低9.11元，成交额达2309.16万元，换手率为1.05%。近日，古汉医药集团股份公司披露《2025年度股东会决议公告》。会议采用现场与网络投票相结合方式，出席股东97人，代表股份占公司有表决权股份总数的49.1778%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700042604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642675984","title":"6月9日古汉医药发布公告，股东增持239.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642675984","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642675984?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:01","pubTimestamp":1781006474,"startTime":"0","endTime":"0","summary":"证券之星消息，6月9日古汉医药发布公告《古汉医药:关于控股股东之一致行动人增持公司股份计划实施期限过半进展暨权益变动触及1%整数倍的提示性公告》，其股东上海赛乐仙企业管理咨询有限公司于2026年5月22日至2026年6月9日间合计增持239.47万股，占公司目前总股本的1.0%，变动期间该股股价下跌7.95%，截止6月9日收盘报9.38元。股东增减持详情见下表：根据古汉医药2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900035139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000590","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793372335600,"stockEarnings":[{"period":"1week","weight":-0.036},{"period":"1month","weight":-0.1214},{"period":"3month","weight":-0.0243},{"period":"6month","weight":-0.2805},{"period":"1year","weight":-0.345},{"period":"ytd","weight":-0.2837}],"compareEarnings":[{"period":"1week","weight":-0.0018},{"period":"1month","weight":-0.0467},{"period":"3month","weight":-0.0472},{"period":"6month","weight":-0.112},{"period":"1year","weight":-0.0909},{"period":"ytd","weight":-0.08}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"古汉医药集团股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15700人(较上一季度增加14.04%)","perCapita":"15245股","listingDate":"1996-01-19","address":"湖南省衡阳市蒸湘区高新区杨柳路33号","registeredCapital":"23947万元","survey":" 古汉医药集团股份公司的主营业务是医药大健康领域的拓展深耕，产品涵盖中药、化药、保健食品三大板块。公司的主要产品是古汉养生精。公司获得了“古汉”商标为中国驰名商标、中华老字号，古汉养生精制作技艺列入湖南省非物质文化遗产。","listedPrice":6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"古汉医药(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供古汉医药(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"古汉医药,000590,古汉医药股票,古汉医药股票老虎,古汉医药股票老虎国际,古汉医药行情,古汉医药股票行情,古汉医药股价,古汉医药股市,古汉医药股票价格,古汉医药股票交易,古汉医药股票购买,古汉医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"古汉医药(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供古汉医药(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}